NLRP3 and Alzheimer disease: In AD models, the NLRP3 inhibitor mefenamic acid was shown to have no effect on pyroptosis, but inhibition or caspase‐1 deficiency protected neuroinflammation and memory deficits in rat models of Aβ‐induced AD.307